Loss of CCDC6, the First Identified RET Partner Gene, Affects pH2AX S139 Levels and Accelerates Mitotic Entry upon DNA Damage by Merolla, Francesco et al.
Loss of CCDC6, the First Identified RET Partner Gene,
Affects pH2AX S139 Levels and Accelerates Mitotic Entry
upon DNA Damage
Francesco Merolla
1,2., Chiara Luise
1,2., Mark T. Muller
3, Roberto Pacelli
4, Alfredo Fusco
1,2,
Angela Celetti
1*
1Istituto di Endocrinologia ed Oncologia Sperimentale, CNR, Naples, Italy, 2Dipartimento di Biologia e Patologia Cellulare e Molecolare, Universita ` Federico II, Naples,
Italy, 3Department of Molecular Biology and Microbiology, College of Medicine, University of Central Florida, Orlando, Florida, United States of America, 4Dipartimento di
Scienze Biomorfologiche e Funzionali, Universita ` Federico II, Naples, Italy
Abstract
CCDC6 was originally identified in chimeric genes caused by chromosomal translocation involving the RET proto-oncogene
in some thryoid tumors mostly upon ionizing radiation exposure. Recognised as a pro-apoptotic phosphoprotein that
negatively regulates CREB1-dependent transcription, CCDC6 is an ATM substrate that is responsive to genotoxic stress. Here
we report that following genotoxic stress, loss or inactivation of CCDC6 in cancers that carry the CCDC6 fusion, accelerates
the dephosphorylation of pH2AX S139, resulting in defective G2 arrest and premature mitotic entry. Moreover, we show
that CCDC6 depleted cells appear to repair DNA damaged in a shorter time compared to controls, based on reporter assays
in cells. High-troughput proteomic screening predicted the interaction between the CCDC6 gene product and the catalytic
subunit of Serin–Threonin Protein Phosphatase 4 (PP4c) recently identified as the evolutionarily conserved pH2AX S139
phosphatase that is activated upon DNA Damage. We describe the interaction between CCDC6 and PP4c and we report the
modulation of PP4c enzymatic activity in CCDC6 depleted cells. We discuss the functional significance of CCDC6-PP4c
interactions and hypothesize that CCDC6 may act in the DNA Damage Response by negatively modulating PP4c activity.
Overall, our data suggest that in primary tumours the loss of CCDC6 function could influence genome stability and thereby
contribute to carcinogenesis.
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Introduction
Exposure to ionizing radiation is a well-known risk factor for
neoplastic transformation especially in thyroid and hematological
tissues [1,2,3]. Chromosomal rearrangements involving the RET
gene, known as RET/PTC, are prevalent in thyroid papillary
carcinomas from patients with radiation exposure history [4,5].
One of the most common radiation induced human papillary
thyroid cancers (PTC) is characterized by the fusion of the
intracellular kinase-encoding domain of RET to the first 101
amino acids of a gene named Coiled Coil Domain Containing 6
(CCDC6) which gives rise to the oncogene named RET/PTC1
[6,7,8]. In individuals exposed to accidental or therapeutic
radiation, RET/PTC1 is the most common type of rearrangement
[1]. Previously unidentified kinase-fusions including CCDC6-RET
have recently been reported in lung adenocarcinoma using an
integrated molecular- and histopathology- based screening system.
In these tumors, the close positive correlation between CCDC6-
RET fusion and radiation exposure justifies further studies [9].
The CCDC6 gene product, also known as H4(D10S170), is
a ubiquitously expressed 65 KDa nuclear and cytosolic protein
lacking significant homology to known genes. A 60 amino acid
fragment of the CCDC6 coiled-coil domain included in the RET/
PTC1 product has been shown to be necessary for homo-
dimerization, constitutive activation and transforming ability of
the oncoprotein [10,11]. In the last few years, large-scale
phosphorylation site-mapping studies identified CCDC6 as
a phosphoprotein [12,13], confirming our previous findings that
CCDC6 is phosphorylated by ERK1/2 at serine 244 upon serum
induction [14,15]. Although the function of wild-type (wt) CCDC6
is ongoing, we previously described the involvement of this gene in
apoptosis and the ability of a truncated mutant (corresponding to
a domain included in RET/PTC1) to act as dominant negative on
nuclear localization and on the wt CCDC6-induced apoptosis
[15]. Furthermore, we reported the involvement of CCDC6
protein in ATM-mediated cellular response to DNA damage,
supporting the idea that impairment of CCDC6 action might play
a key role in carcinogenesis [16]. Further supporting its role in the
control of proliferation, CCDC6 inhibits CREB1-dependent
transcription [17]. Thus, it is possible to postulate that the
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36177transforming potential of RET/PTC1 is not limited to the RET
tyrosine kinase activation, but it may also involve the disruption of
CCDC6 function.
The genome is constantly bombarded with chemical and
radiation-induced damage from internal and external sources [18].
To cope with genotoxic damage, cells activate powerful DNA
damage-induced cell cycle checkpoints that coordinate cell cycle
arrest with recruitment and activation of the DNA repair
machinery [19–23]. The overall importance of these cell cycle
checkpoints in maintaining genomic integrity is highlighted by the
observation that checkpoint pathway genes are often lost, mutated
or silenced in cancer cells [18]. Phosphorylation of H2AX is
among the earliest responses to DNA damage, and controls the
widespread accumulation of checkpoint response proteins to large
chromatin regions surrounding the break sites [24]. Dephosphor-
ylation of pH2AX (the phosphorylated form of H2AX on Ser 139)
and its exclusion from chromatin regions distal to the break sites
are crucial cell cycle re-entry [25]. In this way, the phosphory-
lation status of H2AX constitutes a molecular switch that
maintains genomic integrity.
In this study we have investigated the behaviour of stably
CCDC6 silenced cells and we show the negative effects of CCDC6
depletion on the phosphorylation of H2AX and on the mainte-
nance of G2 arrest following genotoxic exposure. High-troughput
proteomic screening predicted the interaction between CCDC6
and the catalytic subunit of Protein Phosphatase 4 (PP4c) [26],
leading to the dephosphorylation of pH2AX S139 and checkpoint
recovery [27]. In the present study we have further characterized
the interaction between CCDC6 and PP4c.
Results
Loss of CCDC6 Increases Cell Growth and Confers
Resistance to Genotoxic Stress
We generated stably CCDC6 silenced clones by transfecting
HeLa cells with shCCDC6 RNA, in order to examine the impact
of CCDC6 depletion on cellular growth and the genoxicity
responses (Figure 1a). We observed increased growth rates for cells
transfected with two different shCCDC6 RNA derived clones
(Figure 1b). To examine changes in cell cycle progression,
CCDC6-depleted cells were syncronized by double thymidine
block. Based on FACS analysis, we observed that the faster
progression throught the cell cycle was attributed to accelerated
entry into S phase, 2 hours after release, and a faster progression to
G2/M phase at 4 and 6 hours from release (Figure 1c). Finally, we
assessed the survival in two different clones of CCDC6-depleted
cells 48 hours after etoposide treatment at different doses and we
found that these cells were considerably more drug resistant
compared to isogenic control cells (Figure 1d).
Loss of CCDC6 Affects H2AX Phosphorylation After
Double Strand Breaks (DSBs)
We evaluated the phosphorylation status on residue S139 in
H2AX in CCDC6-silenced clones, after genotoxic stress. Thirty
minutes after exposure to different doses of IR (1 and 5 Gy) both
silenced clones showed weak (#1) but detectable (#2) pH2AX
S139 signals relative to the parental HeLa cell controls (Figure 2a).
Thus, at the same dose of IR, the phosphorylation of H2AX
appeared to correlate to the amount of CCDC6 protein (anti-
CCDC6 blot at bottom of figure 2a). In order to understand
whether in CCDC6 depleted cells the effect on H2AX was due to
a reduction in the initial phosphorylation of H2AX or to an
accelerated rate of dephosphorylation, we analysed earlier time
points post-treatment. We found that the initial levels of H2AX
phosphorylation were equivalent in CCDC6 knock-down and
control cells 5 minutes after 1Gy IR exposure, but they decreased
rapidly to barely detectable levels over the next 20–30 min.
(Figure 2b). By immunofluorescence, CCDC6-depleted HeLa
clone#1 cells showed few pH2AX S139 positive foci one hour
post IR exposure compared to control HeLa cells (Figure 2c).
Quantitation of pH2AX S139 foci is shown in Figure 2d. In
CCDC6-depleted cells, re-expression of CCDC6wt (but not of
CCDC6T434A, mutated in the ATM phosphorylation site),
restored pH2AX S139 levels after treatment with Etoposide in
a dose dependent manner. The saturation of pH2AX S139 levels
at 5 mM suggests that CCDC6 is able to modulate pH2AX S139
levels in presence of low DNA damage. At different times post IR,
CCDC6 depletion clearly affected the phosphorylation of H2AX
(relative to controls), even in the presence of phosphorylated ATM
at p-Ser-1981 that correlates with normal ATM activation [28,29]
(Figure 2f).
Loss of CCDC6 Affects the DNA Damage Induced G2-
arrest
In order to investigate whether CCDC6 depletion impacts cell
cycle progression post-DNA damage, depleted cells (shCCDC6)
were double-thymidine synchronized and analyzed. This experi-
ment revealed that control HeLa cells entered mitosis ca. 6–8
hours from release. Etoposide treatment of the control HeLa cells
resulted in delayed entry into mitosis as expected (Figure 3a, top
two panels). In shCCDC6 cells, etoposide treated cells entered
mitosis within 4–6 hours after the initial release and clearly earlier
than the WT control cells. This is based on kinetics of appearance
of the phospho-S/T-MPM2, which measures levels of mitotic
phosphosubstrates (Figure 3a) [30]. The percentage of mitotic cells
was also evaluated by FACS analysis of the anti-pH3 histone-
antibody positive staining (Figure 3b) and by scoring for mitotic
figures (Figure 3c).
Next, we examined Chk1 in CCDC6-depleted cells after
etoposide treatment. Several time points after thymidine release
were evaluated in this experiment. We found that pSer317Chk1
was weakly activated between 2 and 4 hours post DNA damage;
however, it was quickly deactivated in CCDC6 depleted cells
relative to controls (Figure 3d). These data suggest that the
depletion of CCDC6 induces a weak checkpoint response and
introduces cellular tolerance to DNA-damage. To exclude an off-
target effect, we repeated these experiments using either additional
shCCDC6 clones or previously validated siRNA [16] and we
obtained similar results (data not shown).
CCDC6 Loss Affects DNA Repair
A cross talk between checkpoints and DNA repair mechanisms
has been reported [31]. In order to understand if CCDC6 plays
any key role in DSB repair efficiency, we used pulsed-field gel
electrophoresis (PFGE). PFGE monitors DNA sizes released from
genomic DNA by DSBs and thus represents a reasonable metric
for studying DNA repair efficiency since we can track the
reduction in migrating DNA when cells are allowed a recovery
period [32,33]. Using this method, we evaluated repair/recovery
times in shCCDC6-knock down and control cells following
exposure to IR. The data reveal that DSB repair proceeds more
rapidly in shCCDC6 cells (Figure 4a) and may indicate that
CCDC6 depleted cells simply repair DS breaks more efficiently
that the control cells. To examine the overall efficiency of a specific
DSB repair pathway, we utilized a system to quantify NHEJ in
WT and depleted cells. In this system, a single GFP cassette is
mutated by introducing two inverted I-Sce1 homing endonuclease
sites. This reporter cassette (GFP minus) was used to create a stable
Characterization of CCDC6 Loss in Carcinogenesis
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[34]. In these same cells, the Tet-on system was engineered to
control I-SceI gene expression; therefore, in the absence of
doxycycline, I-Sce1 is not present. Within a few hours after
doxycycline addition, I-Sce1 gene is robustly expressed, which
introduces a unique DS DNA break in GFP followed by NHEJ
repair and the appearance of GFP positive cells (Figure 4b). The
number of GFP+ cells reflects the overall efficiency of a specific DS
repair pathway, NHEJ. With this reporter, we observed a clear
increase in GFP-positive cells when CCDC6 was depleted. Note
that I-Sce1 induction was not affected by depletion of CCDC6
(Figure 4b). These data suggest that NHEJ, thought to be a major
pathway for DS break repair in animal cells, operates quickly and
effectively when CCDC6 is depleted.
CCDC6 Interacts with the Catalytic Subunit of PP4
The catalytic subunit of PP4 (PP4c), a member of PPP serin-
threonin-phosphatase family, has been implicated in DNA-
damage response and recently in dephosphorylation of pH2AX
S139 [35,27,36]. Recently, the interaction of PP4c and CCDC6
has been reported; however, the physiological significance of this
interaction has not been reported to our knowledge [27,26]. In
order to pursue this, we transfected 293T cells with myc-tagged
CCDC6 WT or two truncation mutants (CCDC6 1–223; and
CCDC6 1–101). Co-precipitation of PP4c was detected only with
the WT protein, which indicates that the interaction occurs at the
carboxy-terminus of CCDC6. Indeed, RET/PTC1 oncoprotein,
including the first 101 aa of CCDC6 fused to RET tyrosine kinase,
was unable to interact with PP4c (Figure S1). We assessed whether
endogenous PP4c could co-immunoprecipitate CCDC6 at endog-
enous levels. Immunoblotting for CCDC6 revealed the co-
precipitation of a doublet at the expected size (Figure 5b).
Importantly, endogenous CCDC6 immunoprecipitated endoge-
nous PP4c and this interaction should be considered specific
because CCDC6 does not co-IP with other endogenous protein
phosphatases (PP2A, PP6 and Wip, which are phosphatases
reported to be involved in regulation of pH2AX S139 in context of
DNA damage and checkpoint recovery (Figure 5c). To further
Figure 1. Loss of CCDC6 increases cell growth and confers resistance to genotoxic stress. (a) HeLa CCDC6 depleted clones were obtained
after transfection of a plasmid pool of mission ShRNA (pLKo.1 puro ShCCDC6 NM_005436, Sigma-Aldrich) after two weeks puromycin selection.
Immunoblot with anti CCDC6 and a-tubulin were shown. (b) CCDC6-depleted HeLa clones (shCCDC6 #1 and #2) and control HeLa cells (shCTRL)
were plated at 10610
5/dish in triplicate and counted at the indicated times (c) Cell cycle distribution of a stable HeLa CCDC6 silenced clone (shCCDC6
#1) and control HeLa cells (shCTRL) after release from double thymidine block (TT-block) (d) CCDC6-depleted HeLa clones (shCCDC6 #1 and #2) and
control HeLa cells (shCTRL) were plated at 10610
5, treated with the indicated doses of Etoposide and collected at 48 hours. The histograms are
representative of three independent experiments and error bars indicate the standard error mean.
doi:10.1371/journal.pone.0036177.g001
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PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e36177Figure 2. Loss of CCDC6 affects H2AX phosphorylation after DSBs. (a) In the WCL of two representative CCDC6-depleted HeLa clones
(shCCDC6 #1 and #2) and control HeLa cells (shCTRL), thirty minutes after 1–5 Gy IR exposure, the phosphorylation of H2AX was detected with the
mouse anti-pH2AX S139 by western blot. Anti-total H2AX was used as a loading control. The immunoblots with anti-CCDC6 and a-tubulin antibodies
were shown in the bottom. (b) H2AX phosphorylation detection with mouse anti-pH2AX S139 by WCL analysis of CCDC6-depleted Hela clone #1
(shCCDC6) and control cells (shCTRL) at several time points as indicated after exposure to 1Gy of IR. Anti total H2AX is shown as loading control. (c)
Immunofluorescence analysis of pH2AX S139 foci in CCDC6-depleted clone #1 (shCCDC6) and control HeLa cells (shCTRL), thirty minutes after 1, and
5 Gy IR exposure. Nuclei were counterstained with DAPI. Magnification_ was at 63x. (d) Quantification of pH2AX S139 foci number. At least 300 cells
were analysed per experiment. Error bars indicate the standard mean error. (e) CCDC6-depleted clone #1 (shCCDC6) and control HeLa cells (shCTRL)
transfected with expression vectors encoding CCDC6wt, CCDC6T434A or the empty vector were treated with etoposide at 1, 2,5 and 5 mM for 8 h
and western blot analysis of pH2AX S139 and myc-tagged proteins were performed. (f) H2AX phosphorylation detection with mouse anti-pH2AX
S139 by WCL analysis of CCDC6-depleted Hela clone #1 (shCCDC6) and control cells (shCTRL) at several time points as indicated after exposure to
1Gy of IR. Anti total H2AX is shown as loading control. The anti-pSer-1981-ATM and the ATM hybridization are shown at bottom of the figure.
doi:10.1371/journal.pone.0036177.g002
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domains required for this interaction. We tested two truncated
forms of CCDC6 at the C-terminal domain, the CCDC6 (aa. 139–
474) and the CCDC6 (aa. 410–474). Both of these include the
proline-rich region. As shown by the GST-pull down experiments,
we found that in CCDC6 the minimal region of interaction with
PP4c is confined to the Proline-Rich stretch (aa 410–474), as
predicted and also reported for other PP4c interacting proteins,
such as Hpk1 [37] (Figure 5d).
PP4 is a protein complex conserved from yeast to humans and
contains in addition to PP4c, the PP4R2 and PP4R3 regulatory
subunits that control cellular pH2AX S139 [36,27]. In order to
understand if the PP4 regulatory subunits could mediate the
interaction between PP4c and CCDC6 we silenced the R2 and R3
subunits and found that their depletion did not affect the
interaction between CCDC6 and PP4c (Figure 5e, 5f).
CCDC6 Null Cells Possess Elevated PP4c Phosphatase
Activity
We previously reported that CCDC6 is involved in the ATM-
mediated cellular response to DNA Damage [16]. In order to
evaluate the functional outcome of the interaction between
CCDC6 and PP4c, we next investigated if CCDC6 could
modulate the enzymatic activity of the phosphatase on one of its
known substrates, the phospho-Histone H2AX. To this end, we
immunopurified endogenous PP4c in order to retain the complete
subunit composition of the PP4 holoenzyme [38,27]. In the
shCCDC6 cells, the immunopurified PP4 complex showed
elevated activity toward phospho-H2AX-enriched chromatin
(obtained from cells exposed to DNA damage, (Figure S2). The
phosphatase reactions were followed by immunoblotting and
probed with the specific antibodies as shown in Figure 6a.
Immunopurified PP4R2 and R3b were also revealed at immuno-
Figure 3. Loss of CCDC6 affects the DNA damage induced G2 arrest. (a) Mitotic entry of the stable HeLa CCDC6 silenced clone #1 (shCCDC6)
and control HeLa cells (shCTRL) after TT-block and release in 1 mM Etoposide for one hour where indicated, in presence of 50 ng/ml Nocodazole was
monitored by western blot using the anti-p-S/T-MPM2 antibody. Sketch of the cells treatment is shown in the bottom panel. (b) Percentage of
mitotic cells was monitored, by FACS analysis, with anti-p-Ser10-histone H3 staining, in stable CCDC6 silenced and control HeLa cells treated as in (a)
at 8 hours, as indicated. (c) in HeLa CCDC6 silenced clone #1 (shCCDC6) and control HeLa cells (shCTRL) growth on coverslips and collected at
several time points following G1/S syncronization by double thymidine block (TT-block) in the presence of 1 mM Etoposide, as indicated, mitotic
figures were counted after nuclear counterstaining with Dapi. Magnification_ was at 40x. The histograms are representative of three independent
experiments and error bars indicate the standard error mean. (d) After TT-block and release in 1 mM Etoposide stable HeLa CCDC6 silenced clone #1
(shCCDC6) and control HeLa cells (shCTRL) were collected at several time points as indicated. Checkpoint activity was monitored by western blot
using the anti-pSer317-chk1 antibody. Total chk1 is shown at bottom of the figure.
doi:10.1371/journal.pone.0036177.g003
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immunoprecipitated together with PP4c and inferring that the
protein complex might be active. The pH2AX S139 signal, based
on three independent experiments, was normalized against the
intensity of non-phosphorylated H2AX, and against PP4c levels
detected by immunoblotting (Figure S3a). In order to obtain more
accurate measurements of the phosphatase activity, we tested the
activity of PP4 phosphatase on acid-extracted histones from Hela
cells irradiated with a dose of 10 Gy. This method yields enriched
in pH2AX S139 (Figure S4). In CCDC6-depleted HeLa cells
Figure 4. Loss of CCDC6 affects DSBs repair. (a) Detection of DSBs by PFGE. After 10 Gy IR exposure CCDC6-depleted (shCCDC6) and CCDC6-
proficient (shCTRL) HeLa cells have been collected at different time points (1, 2, 4, 24 hours). Densitometric analysis of DSBs bands were plotted as
percentage of total DNA. (b) The percentages of GFP positive cells, compared to controls, have been plotted on the histograms that are
representative of three independent experiments. Error bars indicate the standard error mean. The anti-HA-I-Sce1 and anti-tubulin immunoblots are
shown at bottom of the figure. (c) HeLa cells, bearing the doxycycline-inducible I-Sce1 DNA repair construct, have been transfected with control
shRNAs (shCTRL) or sh-CCDC6 by Microporator MP-100 transfection system (Digital Bio, Korea). The CCDC6 protein depletion was assessed by
western blot analysis for every rate of transfection (#1, #2, #3, #4). The percentages of protein expression, compared to controls, have been plotted
on the histogram below.
doi:10.1371/journal.pone.0036177.g004
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PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e36177Figure 5. CCDC6 interacts with PP4c. (a) 293T cells were transfected with CCDC6 or the CCDC6 (1–223) and (1–101) deleted mutant constructs.
Whole cell lysates (WCL) were prepared and equal amounts of proteins were immunoprecipitated with anti-Myc. Then, the immunocomplexes were
analyzed by western blotting using the indicated antibodies. (b) The co-immunoprecipitation was performed on the endogenous CCDC6 and PP4c
proteins obtained from parental 293T cells. The immunocomplexes were analyzed by western blotting using the indicated antibodies. (c) The co-
immunoprecipitation was performed on the endogenous CCDC6 and the immunocomplexes were analyzed by western blotting using PP4c, PP2A,
PP6c and Wip1 antibodies. (d) GST pull-down assays were performed on WCL from 293T cells and the GST (mock) or GST-CCDC6 fusion proteins. The
bound complexes and WCL were separated on SDS–PAGE and analyzed by western blotting with the indicated antibodies. Coomassie staining is
shown as loading control. (e) (f). In 293T cells, siRNAs targeting specific PP4 regolatory subunits reduced their expression as shown,
coimmunoprecipitation was performed on the endogenous CCDC6 and the immunocomplexes were analysed by western Blot using several
antibodies, as indicated. Mock indicates negative control of immunoprecipitation using an unrelated antibody in a, b, c, d, e and f.
doi:10.1371/journal.pone.0036177.g005
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complex showed increased activity on 3 mg of acid-extracted
histones compared to the activity that we observed in the parental
HeLa cells (shCTRL, Figure 6b). Lastly, we challenged a pro-
portional amount of immunoprecipitated PP4c with 175 mMo f
synthetic phospho-peptide substrate and were able to determine
a linear range of PP4c activity using the same assay (Figure 6c).
To further understand the role of CCDC6 in PP4c activity
modulation we utilized a human CCDC6-null cell line, the thyroid
papillary carcinoma TPC-1 cell line, that carries the RET/PTC1
oncogene and has lost by deletion the normal unrearranged
CCDC6 allele [39]. Then, in TPC-1 cells, in which we transiently
re-expressed the CCDC6 wild type, the phosphatase complex had
poor activity on pH2AX S139 obtained by cells-fractionation
(Figure S2), compared to the activity that immunopurified PP4c
showed in TPC-1 cells overexpressing the CCDC6-truncated
mutants (1–223; 1–101), and both were unable to interact with
PP4c, as revealed by immunoblot (Figure 6d). The phosphatase
reactions were followed by immunoblotting and probed with
specific antibodies as indicated in figure 6d. The densitometric
analysis of pH2AX S139 intensity is shown in Figure S3b.
Moreover, in TPC-1 cells over-expressing WT CCDC6 a pro-
portional amount of the phosphatase complex displayed low
activity on the acid-extracted histones fraction, compared to that
seen with PP4c in the empty vector TPC-1 cells (Figure 6e).
Finally, by using the Malachite Green Assay we were able to
determine a linear range of PP4c activity (Figure 6f). Immuno-
precipitated intact PP4R2 allowed us to modulate the phosphatase
activity on 3 mg of acid-extracted histones and on the synthetic
substrate in Hela-CCDC6-depleted cells compared to Hela
control cells (Figure S5).
Discussion
After exposure to genotoxic stress, depletion of CCDC6
increases dephosphorylation of pH2AX S139 and results in an
early release from G2 checkpoints. Moreover, depletion of
CCDC6 limits the amount of pH2AX S139 which then influences
repair of DSBs. We propose that in these depleted cells, the DNA-
damage checkpoint wavers and a faster but less accurate NHEJ
repair pathway, such as NHEJ takes over, thereby explaining the
expedited repair/recovery time we observe. We additionally
confirmed the predicted interaction between CCDC6 and the
catalytic subunit of Protein Phosphatase 4 [26,40] and that
CCDC6 negatively modulates the phosphatase activity of PP4c on
pH2AX S139, an immediate early marker of DNA double-strand
breaks. It is interesting to note that the depletion of PP4c in
CCDC6 silenced cells rescued back levels of pH2AX S139,
suggesting a functional link between CCDC6-PP4c and pH2AX
S139 in terms of DNA damage sensing pathways (Figure 7a). Our
data suggest that in CCDC6 depleted cells, increased activity of
PP4c results in limited amounts of pH2AX S139; however, it is
also possible that these effects might depend on inactivation of
kinases responsible for H2AX phosphorylation. To address this
point we checked the pSer-1981 ATM which was activated by IR
exposure in CCDC6 depleted and CCDC6 proficient HeLa cells.
PP4isanobligateheterodimerandheterotrimer[40]withatleast
six regulatory subunits that are believed to confer substrate
specificity [36,27]. We found that CCDC6 is important for PP4-
R2-R3 complex to dephosphorylate H2AX. Also it affecs the
phosphorylation status of the DNA repair protein RPA2 (another
PP4c substrate), at least upon genotoxic stress (Figure 7b). Future
studies will help to clarify the impact of CCDC6-PP4c-R2
interaction on RPA2 phosphorylation level upon replicative stress.
Recently, a positive role for PP4c-R2 in HR following Camptothe-
cin treatment was reported [41]. Thus, would be extremely
interesting to evaluate the HR rate in CCDC6 depleted cells in
ordertoinvestigateafunctionallinkbetweenCCDC6-PP4c-pRPA2
and repair, based upon a different kind of stress. It would also be
informative to address whether CCDC6 might influence activity of
the specific PP4 complex on other known phospho-substrates, such
asHDAC3,orJNK,underdifferentconditionsofstress[42,43].We
found that CCDC6 interacted with PP4c but not with PP2A [44].
BothPP2AandPP4belongtothePP2A-likephosphatasefamilyand
are reported to dephosphorylate pH2AX S139; however, it is
believed that each phosphatase plays a different physiological role,
with PP2A functioning mainly after DNA damage, [45,46], and
PP4c mostly involved in replication induced DNA damage and in
DNA-damage checkpoint recovery [36,27]. Recently, PP6c and
Wip1havealsobeenfoundtoexertimportantrolesintheremovalof
pH2AX S139 from chromatin [47,48] whereas PP1c does not alter
pH2AX S139 levels [27]. Thus, several phosphatases (PP2a, PP4c,
PP6c, Wip1) participate directly or indirectly in the dephosphory-
lation of pH2AX S139. While it is still not clear how each
phosphatase contributes to the process, the emerging data suggest
somelevelofredundancyaswellsomecontext-dependentspecificity
[49].
In the present work we postulate that CCDC6 is able to bind to
chromatin (Figure S4) and modulate PP4c at the sites of DNA
damage, as shown by colocalization with a known marker of DNA
damage, such as MDC1 (Figure S6). As CCDC6 lacks a canonical
DNA-binding motif these observations might uncover an un-
expected function of the protein at chromatin level. In addition,
since CCDC6 binds several interactive factors through a large
coiled-coil domain, several post-translational modified residues
and a proline-rich region, it is reasonable to propose it as
a scaffolding protein. On the basis of the data we collected in this
paper we may also envisage a mechanism that could explain the
apoptotic phenotype previously reported in CCDC6 overexpres-
sing cells. Specifically, we hypothesize that CCDC6 negatively
regulates PP4c phosphatase activity, thereby maintaining elevated
levels of pH2AX S139. This would result in the hyperactivation of
a G2/M checkpoint and an increase in the apoptotic rate [15,25].
Moreover, in TPC-1 cells that carry the RET/PTC1 oncogene
and have lost the CCDC6 unrearranged allele, we observed
a decreased PP4c phosphatase activity upon re-expression of wild-
type CCDC6.
The overexpression of protein phosphatase PP4 has already
been reported in some primary tumours [50]. Thus, there may
exist a correlation between the loss (or inactivation) of CCDC6, as
reported in some tumors by the Cancer Genome Atlas (http://
tcga.cancer.gov), and the increase of PP4c phosphatase activity
with the alteration of the G2 checkpoint maintenance and
recovery in human cancer. CCDC6 gene is often found
rearranged to RET and to genes other that RET in thyroid and
non-thyroid human neoplastic diseases [51–54,9]. In all of these
tumours, the fusion results in the loss of function of one allele (and
in some cases of the normal unrearranged allele). Based on this, it
is reasonable to hypothesize that the loss might disrupt the growth
balance contributing to neoplastic transformation.
In conclusion, on the basis of the available data, CCDC6 should
be considered a stress response protein that serves to protect
genome integrity by modulating PP4C activity directed toward
pH2AX S139 dephosphorylation following DNA damage
(Figure 7c). These considerations make CCDC6 an attractive
candidate that could help pre-cancers overcome a Dna Damage
Response (DDR)-dependent barrier against tumour progression
[55]. The loss of checkpoint and of repair accuracy, which we
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instability and might represent an early independent event of
a multistep carcinogenetic process in primary tumours.
Materials and Methods
Materials
Etoposide, crystal violet, thymidine and puromycin were
obtained from Sigma Chemical Co. (St Louis, MO, USA);
Figure 6. CCDC6 inhibits the phosphatase activity of PP4c. (a) PP4 complex immunopurified from HeLa cells transfected with CCDC6-specific
shRNAs (shCCDC6) or with non-targeting control shRNAs (shCTRL), was incubated for 30 minutes at 30uC with pH2AX S139-enriched chromatin
purified from irradiated cells. The phosphatase reactions were followed by western blot and probed with the indicated antibodies. (b) PP4c
phosphatase was immunoprecipitated from shCCDC6 or shCTRL. 1, 0,7, 0,3 voulmes of total PP4c immunoprecipitated from 3 mg of total cell extract
were mixed with 3 mg histones purified from cells exposed to 10 Gy IR and incubated in phosphatase buffer at 30uC for 30 minutes. Phosphatase
reaction was terminated by the addition of 100 ml of Malachite Green solution and absorbance was measured at 630 nm. After the phosphatase
assay, the actual amount of PP4c in each immunoprecipitate was determined by Western Blotting with the indicated antibody. PP4c activity is
represented in arbitrary units (a.u.) calculated as the ratio between released free phosphate (absorbance at 630 nm) and PP4c densitometric signal at
western blot. (c) Enzimatic activity of PP4c immunopurified from HeLa cells transfected with CCDC6-specific shRNA (shCCDC6) or with non-targeting
control sh-RNAs (shCTRL) was assessed by Malachite Green phosphatase assay. 1, 0,7 and 0,3 volumes of total PP4c immunoprecipitated from 3 mg
of total cell extract were incubated with 175 mM of RKpTIRR synthetic peptide for 30 minutes at 30uC. Phosphatase reaction was terminated by the
addition of 100 ml of Malachite Green solution and absorbance was measured at 630 nm. After the phosphatase assay, the actual amount of PP4c in
each immunoprecipitate was determined by Western Blotting with the indicated antibody. PP4c activity is represented in arbitrary units (a.u.)
calculated as the ratio between released free phosphate (absorbance at 630 nm) and PP4c densitometric signal at western blot. (d) PP4 complex
immunopurified from TPC-1 cells transfected with CCDC6 wt, CCDC6 (1–223) and (1–101) truncated mutants, was incubated for 30 minutes at 30uC
with pH2AX S139-enriched chromatin, purified from irradiated cells. The phosphatase reactions were followed by immunoblotting and probed with
the indicated antibodies. (e)( f) Enzimatic activity of PP4c immunopurified from TPC-1 cells transfected with epitope-tagged CCDC6 wt or empty
vector, was determined as described in (b) and (c).
doi:10.1371/journal.pone.0036177.g006
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tidine hydrochloride from Fluka. Okadaic acid was from Biomol
International (Farmingdale, New York).
Immunoblotting and immunoprecipitation experiments were
carried out according to standard procedures and visualized using
the ECL chemiluminescence system (Amersham/Pharmacia Bio-
tech). The list of antibodies is reported in supplementary
experimental procedures and materials (File S1).
Cell Culture, Plasmids and Transfection
TPC-1 [39] and 293T [56] cells were maintained in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal bovine
serum. HeLa cells [57] were maintained in RPMI (Gibco, Paisley,
UK), supplemented with 10% fetal bovine serum. TPC-1 cells
were kindly obtained by Massimo Santoro. 293T and HeLa cells
were obtained by ATCC.
GST-CCDC6 fusion proteins production and Small inhibitor
duplex RNAs targeting human CCDC6 were described elsewhere
[16].
Mission shRNA (pLKO.1 puro) were from Sigma-Aldrich, Inc.
For stable transfection assays the HeLa cells were transfected
with the plasmid pool (shCCDC6, NM_005436) or a pool of non-
targeting vectors (sh control) by the Nucleofector transfection
system.
Flow Cytometry
Cells at 70% confluence were harvested, fixed in ethanol for 1 h
at 220uC, rehydrated in PBS for 1 h at 4uC, and then treated with
RNase A (100 U/ml) for 30 min. Propidium iodide (25 mg/ml)
was added to the cells for 30 min in the dark at room temperature.
The percentage of the M-phase cells was determined by staining
with PI and antibody to phospho-histone H3 (P-H3) (Cell
Signaling, Beverly, MA, USA), followed by FITC-conjugated
secondary antibody (Jackson Immunoresearch Laboratories, West
Grove, PA, USA). Samples were analysed with a FACScan flow
cytometer (Becton Dickinson, San Jose, CA, USA) and data were
analysed with Modfits software.
Phosphatase Assays
Chromatin fractions were purified by HeLa cells after 10 Gy IR
exposure as indicated in Supplementary Legends to figure 2a.
Crude histones were isolated by acidic extraction from cells
exposed to IR (10Gy, 1 h) using a Histone purification kit (Active
Motif, Carlsbad, CA, USA). 293T cells were lysed in buffer
containing 60 mM Tris-HCl (pH 8.0), 1% Nonidet P-40, 120 mM
NaCl, 1 mM EDTA, 6 mM EGTA, 1 mM dithiothreitol, 50 mM
p-amidinophenylmethanesulfonyl-Fluoride and 2 mg/ml aproti-
nin. Endogenous PP4 was immunoprecipitated with an anti-PP4C
antibody. The immunoprecipitates were washed three times in
washing buffer. Phosphatase assays were performed incubating the
PP4C immunoprecipitated with purified chromatin fraction or
mixed with 3 micrograms of acid-extracted histones in 40 mlo f
assay buffer (50 mM Tris pH 7.0, 0.1 mM CaCl2, and 1 mM
MnCl2) at 30uC for 30 min (unless otherwise indicated). Buffer
plus chromatin fraction was used as a negative control, boiled in
a SDS-PAGE loading buffer for 5 min, resolved by 15% SDS-
PAGE, transferred to nitrocellulose membranes, and then
subjected to Western blotting with the indicated antibodies.
Enzimatic activity of PP4c on acid-extracted histones or on
synthetic RKpTIRR phosphorylated substrate was detected by the
Figure 7. CCDC6 in the genome stability control. (a) shCCDC6 and shCTRL HeLa cells were depleted of PP4c by shRNA (48 hours) and were
exposed to 1 Gy of IR, as indicated (2/+). Phosphorylation of H2AX, PP4c, CCDC6, total H2AX and tubulin amount were revealed at IB of WCL. (b)I n
the cell extract of CCDC6-depleted clone #1 (shCCDC6) and control HeLa cells (shCTRL), after double thymidine block (TT block) and release in
presence of 1 mM Etoposide at several time point, as indicated, phosphorylation levels of H2AX and of RPA2 were revealed with anti-pH2AX S139 and
with anti-p-RPA2 by western blot. Anti-total H2AX and anti-total RPA were shown as loading control. (c) Schematic diagram of CCDC6 function in
modulating PP4c activity on the phosphorylation status of H2AX in the DNA-damage response.
doi:10.1371/journal.pone.0036177.g007
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protocol (Upstate Biotechnology Inc, Lake Placid, NY).
G2/M Checkpoint Recovery Assay
The cells were synchronized in G1/S phase by double
thymidine-block, 1 mM etoposide treated for one hour and
released in 50 ng/ml of Nocodazole. Immunoblots with phos-
pho-S/T-MPM2 antibody were performed on lysates at single
time points of cell extracts obtained from CCDC6 depleted and
control cells.
DSBs Detection by PFGE
Standard conditions for the DSBs compaction in one band were
adapted to the CHEF DRIII apparatus (BIORAD) from Hanada
et al., 2007 [58].
NHEJ Reporter Cell Assays
The NHEJ-I reporter is based on a construct from Mao et al.
[34] that consists of a GFP cassette, interrupted by an internal
adenoviral exon and a Neomycin selectable marker. The cassette
additionally contains a CMV promoter; however, cells that
contain the NHEJ-I reporter are GFP negative due to the
adenoviral exon insertion. Flanking the adenoviral exon are two I-
Sce1 sites that are in an inverted orientation. Following digestion
with the homing endonuclease I-Sce1, double strand break appear
that define incompatible ends, which are repaired by NHEJ. To
create the I-Sce1 inducible cell reporter, a stable HeLa cell line
containing a single integrated copy of the NHEJ-I reporter was
first selected and characterized. Two lentiviruses (pLV-TetO-HA-
SceI and rtTA) were used to co-infect this stable cell line and
screening was performed to identify a single clone that could be
induced by Doxycycline to produce GFP+ cells in a Tet-on format.
Following induction of the I-Sce1 gene by doxycycline, DS DNA
breaks are produced that flank the adenoviral exon. The breaks
are repaired by NHEJ and the cells produce wild type GFP. The
number of GFP positive cells was enumerated by microscopy.
Supporting Information
Figure S1 293T cells were transfected with CCDC6wt or
the PTC1 constructs. Whole cell lysates (WCL) were prepared
and equal amounts of proteins were immunoprecipitated with
anti-myc. Then, the immunocomplexes were analyzed by western
blotting using anti-PP4C and anti-myc antibodies. Mock indicates
negative control of immunoprecipitation using an unrelated
antibody.
(DOC)
Figure S2 Chromatin fractions were purified by HeLa
cells after 10 Gy IR exposure, as reported in Supple-
mentary experimental procedures (File S1). Enriched
phosphorylated H2AX is shown in the chromatin fraction. The
anti CCDC6 hybridization shows that a quote of CCDC6 is also
localized on chromatin.
(DOC)
Figure S3 Histograms in a and b show the densitomet-
ric analysis of pH2AX S139 intensity, resolved on SDS-
PAGE following phosphatase reactions, normalized
against the intensity of non-phosphorylated histone
H2AX, and against the PP4c levels on immunoblots.
The histograms are representative of three independent experi-
ments and error bars indicate the standard error mean.
(DOC)
Figure S4 a) Irradiated HeLa cells (10Gy) were lysed,
and histones were acid-extracted. Samples obtained from
histone extraction (Acid extraction) and whole cell lysates were
separated by SDS-PAGE and stained with Coomassie blue. b)
Mock (-) or irradiated HeLa cells (+, 10 Gy) were acid-
extracted to purify total histones as in a). Various amount
of proteins were separated by SDS-PAGE and transferred to
nitrocellulose mambranes that were hybridized with pH2AX S139
specific antibody.
(DOC)
Figure S5 Phosphatase assay has been performed by
immunopurifying PP4R2 as means of immunopurifying
PP4c in complex with the regulatory subunits. The
phosphatase complex by immunoprecipitating proportional
amount of PP4R2, was immunoprecipitated from CCDC6
depleted and CCDC6 proficient HeLa cells and mixed with
3 ug of acid extracted histones at 30uC for 30 minutes.
Phosphatase reactions were terminated by the addiction of
100 mL of Malachite Green solution and absorbance was
measured at 630 nm.
(DOC)
Figure S6 MDC1 foci formed in HeLa cells colocalized
with CCDC6, upon 1Gy IR exposure. The cells were fixed
and stained with anti-MDC1, CCDC6, and DAPI, and visualized
at fluorescence microscopy. CCDC6 colocalize in most of the
MDC1 foci formed upon IR exposure.
(DOC)
File S1 Supplementary experimental procedures and
materials.
(DOC)
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